PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons

Related Articles
Design and Evolution: Molecular Sleuthing Reveals Drug Selectivity
June 2015
Families in Gene Neighborhoods
June 2015
Ryanodine Receptor
April 2015
CCR5 and HIV Infection
January 2015
Drug Targets: Bile Acids in Motion
September 2014
Drug Targets: S1R's Ligands and Partners
September 2014
P2Y Receptors and Blood Clotting
September 2014
Bacterial CDI Toxins
June 2014
Glucagon Receptor
April 2014
March 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Design and Discovery: Virtual Drug Screening
January 2014
Cancer Networks: IFI16-mediated p53 Activation
November 2013
G Proteins and Cancer
November 2013
Drug Discovery: Antidepressant Potential of 6-NQ SERT Inhibitors
October 2013
Drug Discovery: Finding Druggable Targets
October 2013
Drug Discovery: Identifying Dynamic Networks by CONTACT
October 2013
Drug Discovery: Modeling NET Interactions
October 2013
Membrane Proteome: GPCR Substrate Recognition and Functional Selectivity
August 2013
Infectious Diseases: Determining the Essential Structome
May 2013
NDM-1 and Antibiotics
May 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Cytochrome Oxidase
November 2012
Membrane Proteome: The ABCs of Transport
November 2012
Bacterial Phosphotransferase System
October 2012
Regulatory insights
September 2012
Solute Channels
September 2012
Pocket changes
July 2012
Receptor bias
July 2012
Anthrax Stealth Siderophores
June 2012
G Protein-Coupled Receptors
May 2012
Substrate specificity sleuths
April 2012
Reading out regioselectivity
December 2011
Superbugs and Antibiotic Resistance
December 2011
Terminal activation
December 2011
A change to resistance
November 2011
Docking and rolling
October 2011
Breaking down the defenses
September 2011
A2A Adenosine Receptor
May 2011
Cell wall recycler
May 2011
Subtly different
March 2011
January 2011
Subtle shifts
January 2011
ABA receptor diversity
November 2010
COX inhibition: Naproxen by proxy
November 2010
Zinc Transporter ZntB
July 2010
Peptidoglycan binding: Calcium-free killing
June 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Antibiotics and Ribosome Function
March 2010
Safer Alzheimer's drugs?
March 2010
Anthrax evasion tactics
September 2009
GPCR subunits: Separate but not equal
September 2009
Antibiotic target
August 2009
Salicylic Acid Binding Protein 2
August 2009
July 2009
Tackling influenza
June 2009
Bacterial Leucine Transporter, LeuT
May 2009
Anthrax stealth molecule
March 2009
Drug targets to aim for
February 2009
High-energy storage system
February 2009
Transporter mechanism in sight
February 2009
Scavenger Decapping Enzyme DcpS
November 2008
Blocking AmtB
September 2008

Research Themes Drug discovery

Drug Discovery: Finding Druggable Targets

SBKB [doi:10.1038/sbkb.2012.166]
Technical Highlight - October 2013
Short description: A guide to selecting strategic targets for pharmacological intervention and drug design in microbiomes is presented for Streptococcus mutans.

A druggable target protein from S. mutans. A highly reliable structural model for uracil-diphosphate acetyl-glucosamine epimerase, shown by hydropathy plot (red as hydrophobic, blue as hydrophilic) and featuring a long, narrow pocket for drug binding. Figure courtesy of Jeremy Horst.

Genomic sequences of many bacterial species are now available, and having the entire derived proteome at hand offers many opportunities for drug development. However, one still needs to find the appropriate targets among the proteome. Horst and colleagues (PSI NYSGRC) have developed a strategy to identify potential drug targets in the bacterium Streptococcus mutans in the context of other dental plaque bacteria.

Dental caries cause irreversible damage to teeth and represent a heavy burden on global public health. Many factors contribute to the etiology of dental caries, including dietary sugars and the presence of certain bacterial species in dental plaque. While some species such as S. mutans are cariogenic, others can have a protective effect. Thus, a potential way to prevent and combat dental caries is to specifically target the cariogenic bacteria while preserving those that are non-cariogenic.

The authors followed three analytical steps to find useful drug targets among the 2,391 predicted proteins in S. mutans. First, they used MODELLER-v9.10, a restraint-based comparative modeling program, to produce models of 1,631 proteins, of which 616 were considered highly reliable (available at ModBase). Next, they assessed those 616 models along with 81 structures available in the PDB for “druggability,” i.e., the presence of favorable drug-binding sites, whittling the list to 110 proteins. Those included 15 virulence factors, 16 proteins with available crystal structures and 84 previously unidentified proteins.

Finally, the authors examined the specificity of these targets, by generating phylogenetic profiles for each of those proteins, among other cariogenic (target) and non-cariogenic (antitarget) bacteria. Unfortunately, none of the druggable proteins identified were differentially abundant among cariogenic bacteria, indicating that drugs designed against those proteins would affect the non-cariogenic species as well. This arose due to a lack of sufficient structural templates for the etiologic proteins and their control mechanisms.

It is likely that there are druggable and specific target proteins among S. mutans and other cariogenic bacteria that could not be modeled in this work. This limitation should be overcome as more protein structures become available. Nevertheless, the work provides a valuable map to streamline target selection for rational drug discovery against chronic multibacterial diseases.

Inês Chen


  1. J.A. Horst et al. Strategic protein target analysis for developing drugs to stop dental caries.
    Adv Dent Res. 24, 86-93 (2012). doi:10.1177/0022034512449837

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health